Novo CEO pressed by Senate to cut price ranges of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers about the checklist prices of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. https://eduardomdujz.digiblogbox.com/55845623/the-healthcare-news-diaries